Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327587 · ClinicalTrials.gov registry record · Phase 3
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,279
- Enrollment target
NCT00327587: Completed Phase 3 study, sponsored by Novartis.
NCT00327587 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 2,279 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (195% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00327587, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,279 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan, HCTZ, and amlodipine in patients with moderate to severe hypertension.
Interventions
- DRUG Valsartan + HCTZ
- DRUG Valsartan + amlodipine
- DRUG Amlodipine + HCTZ
- DRUG Valsartan + amlodipine + HCTZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,279 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
What the finished NCT00327587 record still lists
NCT00327587 is an interventional study that assigns participants to a tested intervention. Its 2,279 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (195% higher).
The record links to 0 conditions, and to 4 interventions - of which Valsartan + HCTZ is the first listed.
NCT00327587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00327587 about?
NCT00327587 is a clinical study titled "8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension". The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan, HCTZ, and amlodipine in patients with moderate to severe hypertension.
What is the current status of trial NCT00327587?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,279 participants. The study started on 2006-05. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00327587?
The interventions under investigation include: Valsartan + HCTZ (DRUG), Valsartan + amlodipine (DRUG), Amlodipine + HCTZ (DRUG), Valsartan + amlodipine + HCTZ (DRUG).
Who is sponsoring clinical trial NCT00327587?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00327587's enrollment target sits among peer trials
2,279 94th of 2000 higher than 1,907 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia